Full Press Release Details
IDEAYA Receives Authorization to Proceed with Phase 1 2 Tissue Type Agnostic Basket Trial to Treat Patients with Tumors Harboring GNAQ 11 Mutations and PKC Fusions.
IDYA
IDEAYA Receives Authorization to Proceed with Phase 1 2 Tissue Type Agnostic Basket Trial to Treat Patients with Tumors Harboring GNAQ 11 Mutations and PKC Fusions
Key Takeaway: IDEAYA Receives Authorization to Proceed with Phase 1 2 Tissue Type Agnostic Basket Trial to Treat Patients with Tumors Harboring GNAQ 11 Mutations and PKC Fusions